-Electrek
https://twitter.com/ElectrekCo/status/1620375608441053184
Zynex Reports Preliminary Q1 2023 Results; Sees Q1 EPS $0.00-$0.03 Vs $0.01 Est.; Q1 Revenue $39M-$41M Vs $39.61M Est; Sees FY23 EPS $0.40-$0.50 Vs $0.47 Est.; FY23 Revenue $180M-$200M Vs $191.24M Est.;
Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today
